DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 192-200

  Aposhian, H Vasken ^a   Arroyo, Alex ^b   Cebrian, Mariano E ^c   Del Razo, Luz María ^c   Hurlbut, Katherine M ^d   Dart, Richard C ^d   Gonzalez Ramirez, Diego ^e   Kreppel, Helmut ^f   Speisky, Hernan ^g   Smith, Allan ^h   Gonsebatt, Maria E ⁱ   Ostrosky Wegman, Patricia ⁱ   Aposhian, Mary M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b Ministerio de Salud   (Chile)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d Rocky Mt Poison Drug Contr Ctr   (United States)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF CHILE   (Chile)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CACODYLIC ACID; CHELATING AGENT; DRINKING WATER; METHANEARSONIC ACID; UNITHIOL;

ADULT; ARTICLE; BODY BURDEN; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; TOXICOKINETICS; URINARY EXCRETION; WATER CONTAMINATION;

ADULT; ANTIDOTES; ARSENICALS; FEMALE; HUMANS; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MIDDLE AGED; UNITHIOL; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 14444269661     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. AASETH, J., JACOBSEN, D., ANDERSEN, O. AND WICKSTROM, E.: Treatment of mercury and lead poisonings with dimercapto succinic acid and sodium dimercaptopropanesulfonate: A review. Analyst 120: 853-854, 1995.
2. APOSHIAN, H. V.: Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol., in press, 1997.
3. APOSHIAN, H. V.: DMSA and DMPS-water soluble antidotes for heavy metal poisoning. Annu. Rev. Pharmacol. Toxicol. 23: 193-215, 1983.
4. APOSHIAN, H. V. AND APOSHIAN, M. M.: Meso-2,3-dimercaptosuccinic acid: Chemical, pharmacological and texicological properties of an orally effective chelating agent. Annu. Rev. Pharmacol. Toxicol. 30: 279-306, 1990.
5. APOSHIAN, H. V., BRUCE, D. C., ALTER, W., DART, R. C., HURLBUT, K. M. AND APOSHIAN, M. M.: Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score. FASEB J. 6: 2472-2476, 1992.
6. APOSHIAN, H. V., MAIORINO, R. M., GONZALEZ-RAMIREZ, D., ZUNIGA-CHARLES, M., Xu, Z., HURLBUT, K. M., JUNCO-MUNOZ, P., DART, R. C. AND APOSHIAN, M. M.: Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 97: 23-38, 1995.
7. APOSHIAN, H. V., ZAKHARYAN, R. A., Wu, Y., HEALY, S. AND APOSHIAN, M. M.: Enzymatic methylation of arsenic compounds: II. An overview. In Arsenic Exposure and Human Health II, ed. by C. Abernethy, R. Calderon, W. Chappell, Chapman & Hall, London, in press, 1997.
8. BUCHET, J. P. AND LAUWERYS, R.: Role of thiols in the in-vitro methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 37: 3149-3153, 1988.
9. CEBRIAN, M. E., ALBORES, A., AGUILAR, M. AND BLAKELY, E.: Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol. 2: 121-133, 1983.
10. CHATTERJEE, A., DAS, D., MANDAL, B. K., CHOWDHURY, T. R., SAMANTA, G. AND CHAKRABORTY, D.: Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part I. Arsenic species in drinking water and urine of the affected people. Analyst 120: 643-650, 1995.
11. CHEN, C. J., CHUANG, Y. C., LIN, T. M. AND Wu, H. Y.: Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: higharsenic artesian well water and cancers. Cancer Res. 45: 5895-5899, 1985.
12. CHEN, S. L., YEH, S. J., YANG, M. H. AND LIN, T. H.: Trace element concentration and arsenic speciation in the well water of a Taiwan area with endemic Blackfoot Disease. Biol. Trace Elem. Res. 48: 263-274, 1995.
13. Cox, D. H.: Arsine evolution-electrothermal atomic absorption method for the determination of nanogram levels of total arsenic in urine and water. J. Anal. Toxicol. 4: 207-211, 1980.
14. CRECELIUS, E.: Speciation of Selenium and Arsenic in Natural Waters and Sediments, Vol. 2: Arsenic Speciation. EPRI EA-4641s, 1986.
15. DEL RAZO, L. M., ARELLANO, M. A. AND CEBRIAN, M. E.: The oxidation states of arsenic in well water from a chronic arsenicism area of northern Mexico. Environ. Poll. 64: 143-153,1990.
16. DEL RAZO, L. M., GARCIA-VARGAS, G. G, VARGAS, H., ALBORES, A., GONSEBATT, M. E., MONTERO, R., OSTROSKY-WEGMAN, P., KELSH, M. Y. AND CEBRIAN, M. E.: Altered profile of urinary arsenic metabolites in adults with chronic arsenism. A pilot study. Arch. Toxicol., in press, 1997.
17. FARMER, J. G. AND JOHNSON, L. R.: Assessment of occupational exposure to inorganic arsenic based on urinary concentrations and speciation of arsenic. Br. J. Ind. Med. 47: 342-348, 1990.
18. GONSEBATT, M. E., VEGA, L., SALAZAR, A. M., MONTERO, R., GUZMAN, P., BLAS, J., DEL RAZO, L. M., GARCIA-VARGAS, G., ALBORES, A., CEBRIAN, M. E., KELCH, M. AND OSTROSKY-WEGMAN, P.: Clastogenicity of arsenic exposure. Mutat. Res., in press, 1997.
19. GONZALEZ-RAMIREZ, D., MAIORINO, R. M., ZUNIGA-CHARLES, M., Xu, Z., HURLBUT, K. M., JUNCO-MUNOZ, P., APOSHIAN, M. M., DART, R. C., DIAZ GAMA, J. H., ECHEVERRIA, D., WOODS, J. S. AND APOSHIAN, H. V.: Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. J. Pharmacol. Exp. Ther. 272: 264-274, 1995.
20. GUHA MAZUMDER, D. N., CHAKRABORTY, A. K., GHOSE, A., GUPTA, J. D., CHAKRABORTY, D. P. AND DEY, S. B.: Chronic arsenic toxicity from drinking water in rural West Bengal. Bull. WHO 66: 499-506, 1988.
21. HAGMAR, L., BROGGER, A., HANSTEEN, I-L., HEIM, S., HOGSTED, B., KNUDSEN, L., LAMBERT, B., LINNAINMAA, K., MITELMAN, F., NORDENSON, L, REUTERWALL, C., SALORNAA, S., SKERFVING, S. AND SORSA, M.: Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Res. 54: 2919-2922, 1994.
22. HEALY, S. M., ZAKHARYAN, R. A. AND APOSHIAN, H. V.: Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutat. Res., in press, 1997.
23. HOPENHAYN-RICH, C., BIGGS, M. L., KALMAN, D. A., MOORE, L. E. AND SMITH, A. H.: Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ. Health Perspect. 104: 1200-1207, 1996.
24. HOPENHAYN-RICH, C., SMITH, A. H. AND GOEDEN, H. M.: Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60: 161-177, 1993.
25. IARC: Arsenic and arsenic compounds. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some Metals and Metallic Compounds. World Health Organization, Lyon, France 23: 39-141, 1980.
26. KEMPER, F. H., JEKAT, F. W., BERTRAM, H. P. AND ECKARD, R.: New chelating agents. In Basic Science in Toxicology, Proceedings of the 5th International Congress of Toxicology, England 1989, ed. by G. N. Volans, J. Sims, F. M. Sullivan and P. Turner, pp. 523-546, Taylor & Francis Ltd, London, 1990:
27. LORSCHEIDER, F. L., VIMY, M. J. AND SUMMERS, A. O.: Mercury exposure from "silver" tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB J. 9: 504-08, 1995.
28. MAIORINO, R. M. AND APOSHIAN, H. V.: Dimercapto metal-binding agents influence the biotransformation of arsenite in the rabbit. Toxicol. Appl. Pharmacol. 77: 240-250, 1985.
29. MAIORINO, R. M., DART, R. C., CARTER, D. E. AND APOSHIAN, H. V.: Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmaco-kinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. J. Pharmacol. Exp. Ther. 259: 808-814, 1991.
30. MAIORINO, R. M., GONZALEZ-RAMIREZ, D., ZUNIGA-CHARLES, M., Xu, Z., HURLBUT, K. M., APOSHIAN, M. M., DART, R. C., WOODS, J. S., OSTROSKY-WEGMAN, P., GONSEBATT, M. E. AND APOSHIAN, H. V.: Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. J. Pharmacol. Exp. Ther. 277: 938-944, 1996.
31. NATIONAL RESEARCH COUNCIL REPORT: Medical and Biologic Effects of Environmental Pollutants, Arsenic National Academy of Sciences, Washington, DC, 1977.
32. NUÑEZ-ATENCIO, L. N., HILL, H. G. AND MARTÍNEZ, A. L.: Guía Museo Arqueológico, Universidad Católica del Norte Chile. San Pedro de Atacama (II Región): Institute de Invetigaciones Arqueologicas y Museo R. P. Gustavo Le Paige S. J., 1991.
33. OFFERGELT, J. A., ROELS, H., BUCHET, J. P., BOECKX, M. AND LAUWERYS, R.: Relation between airborne arsenic trioxide and urinary excretion of inorganic arsenic and its methylated metabolites. Br. J. Ind. Med. 49: 387-393, 1992.
34. ROSIN, M. P.: Micronuclei as intermediate end points in intervention. In The Biology and Prevention of Aerodigestive Tract Cancers, ed. by G. R. Newell and W. K. Wong, pp. 95-105, Plenum Press, New York, 1992.
35. SANCHA, A. M., VEGA, F., VENTURINO, H., FUENTES, S., SALAZAR, A. M., MORENO, V., BARON, A. M. AND RODRIGUEZ, D.: The arsenic health problem in northern Chile evaluation and Control. A case study preliminary report. In Procceedings of the International Seminar. Arsenic in the Environment and Its Incidence on Health, pp. 187-202, Universidad de Chile, Santiago, Chile, 1992.
36. STYBLO, M., DELNOMDEDIEU, M. AND THOMAS, D.: Biological mechanisms and toxicological consequences of the methylation of arsenic. In Toxicology of Metals-Biochemical Aspects, Handbook of Experimental Pharmacology, v. 115, ed. by M. G. Cherian and R. A. Goyer, pp. 407-433, Springer Verlag, Berlin, 1995a.
37. STYBLO, M., YAMAUCHI, H. AND THOMAS, D.: Comparative in vitro methylation of trivalent and pentavalent arsenicals. Toxicol. Appl. Pharmacol. 135: 172-178, 1995b.
38. TOLBERT, P. E., SHY, C. M. AND ALLEN, J. W.: Micronuclei and other anomalies in buccal smears: methods development. Mutat. Res. 271: 69-77, 1992.
39. TSENG, C. H., CHONG, C. K., CHEN, C. J. AND TAI, T. Y.: Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in Blackfoot Disease endemic villages in Taiwan. Atherosclerosis 120: 125-133, 1996.
40. TSENG, W. P.: Effects and dose-response relationships of skin cancer and Blackfoot Disease with arsenic. Environ. Health Perspect. 19: 109-119, 1977.
41. VAHTER, M.: Metabolism of inorganic arsenic in relation to chemical form and animal species, Ph.D. Thesis, Karolinska Institute and National Institute of Environmental Medicine, Stockholm, Sweden, 1983.
42. VAHTER, M., CONCHA, G., NERMELL, B., NILSSON, R., DULUOT, F. AND NATARAJAN, A.: A unique metabolism of inorganic arsenic in native Andean women. Eur. J. Pharmacol. 293: 455-462, 1995a.
43. VAHTER, M., COUCH, R., NERMELL, B. AND NILSSON, R.: Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 133: 262-268, 1995b.
44. VAHTER, M. AND LIND B.: Concentrations of arsenic in urine of the general population in Sweden. Sci. Total Environ. 54: 1-12, 1986.
45. WORLD HEALTH ORGANIZATION: Guidelines for drinking-water quality. Vol. 1. Recommendations. World Health Organization, Geneva, 1996.
46. YAMAUCHI, H., TAKAHASHI, K., MASHIKO, M., SAITOH, J. AND YAMAMURA, Y.: Intake of different chemical species of dietary arsenic by Japanese, and their blood and urinary arsenic levels. Appl. Organomet. Chem. 6: 383-388, 1992.
47. ZAKHARYAN, R. A., WILDFANG, E. AND APOSHIAN, H. V.: Enzymatic methylation of arsenic compounds: III. The marmoset and tamarin, but not the rhesus, monkey are deficient in methyltransferases that methylate inorganic arsenic. Toxicol. Appl. Pharmacol. 140: 77-84, 1996.
48. ZAKHARYAN, R. A., Wu, Y., BOGDAN, G. M. AND APOSHIAN, H. V.: Enzymatic methylation of arsenic compounds. I: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8: 1029-1038, 1995.